港股異動丨達勢股份續升超6% 股價創歷史新高 較發行價已逼近翻倍!
達勢股份(1405.HK)午後升幅擴大,一度升超6%至91.7港元,股價創歷史新高,市值超120億港元。該股自2023年在港交所上市以來連年上升,現價較發行價46港元已逼近翻倍。達勢背靠全球最大比薩品牌達美樂,是達美樂在中國內地及中國香港、澳門的獨家特許經營商。廣發證券發研報給予達勢股份“買入”評級,該行指,達美樂具有較強的品牌勢能,且在中國市場仍處於上升期,快速拓店的同時仍能保持同店增長,對標同行潛在展店空間較大,未來盈利能力改善路徑清晰。此外,美銀證券認為,在基準情境下,預計今年將開始逐步和有針對性的消費者刺激措施出台。考慮到企業每股盈利、政策及中美不確定性,該行偏好於防禦型的股份,並調整內需股目標價。其中,將達勢股份的目標價由78.3港元大幅上調至91.3港元,評級“買入”。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.